R. Greil

Elite controllers or misquantification of virus load by Cobas TaqMan? (2008)

Taylor, N, Jauer, M, Bijuklic, K, Egle, A, Greil, R, Patsch, W, ...

No abstract available.

Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study (2008)

Von Moos, R., Caspar, C. B., Thürlimann, B., Angst, R., Inauen, R., Greil, R., ...

Background: Clinical data show that a single, 15-min i.v. infusion of ibandronate 6 mg does not significantly alter renal function. We evaluated the effect on renal function of repeated 15-min...

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines (2008)

Schmid, P., Kühnhardt, D., Kiewe, P., Lehenbauer-Dehm, S., Schippinger, W., Greil, R., ...

Background: Proteasome inhibitors are a novel class of compounds entering clinical trials as a method to increase tumour sensitivity to standard chemotherapy. This phase I/II trial was carried out to...

Erythropoietins in cancer patients: ESMO Recommendations for use (2008)

Greil, R., Thödtman, R., Roila, F.

Hematopoietic growth factors: ESMO Recommendations for the applications (2008)

Greil, R., Psenak, O., Roila, F.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma (2005)

Greil, R., Kloke, O.

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients (2005)

Fey, M. F., Greil, R., Jost, L. M.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia (2005)

Hallek, M., Stahel, R. A., Greil, R.

ESMO recommendations for the application of hematopoietic growth factors (2005)

Greil, R., Jost, L. M.

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial (2004)

Sieber, M., Tesch, H., Pfistner, B., Rueffer, U., Paulus, U., Munker, R., ...

Background: The purpose of this study was to compare the efficacy of the hybrid chemotherapeutic regimen COPP/ABV/IMEP...

Intravascular large B-cell lymphoma with a fulminant clinical course: a case report with definite diagnosis post mortem (2002)

Fiegl, M., Greil, R., Pechlaner, C., Krugmann, J., Dirnhofer, S.

A patient is described who presented with pancytopenia, splenomegaly and excessively elevated lactate dehydrogenase levels in concurrence with signs of extramedullary hematopoiesis. Although...

The impact of hemoglobin levels on fatigue and quality of life in cancer patients (2002)

Holzner, B., Kemmler, G., Greil, R., Kopp, M., Zeimet, A., Raderer, M., ...

Background Although fatigue is a commonly reported symptom in cancer patients its etiology is still poorly understood. The objective of the present study was to investigate the relationship between...

Vinorelbine--gemcitabine in advanced non-small-cell lung cancer (NSCLC): An AASLC phase II trial (2000)

Krajnik, G., Mohn-Staudner, A., Thaler, J., Greil, R., Schmeikal, S., Marhold, F., ...

Purpose The purpose of the present phase II trial was to determine the efficacy and toxicity of vinorelbine—gemcitabine in patients with advanced non-small-cell lung cancer (NSCLC). Patients and...

Abstract (1992)

Strohscheer, I., Kleinert, R., Westphal, C., Schüller, J., Werner, K., Anders, O., ...

Peer Reviewed

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas

Krugmann, J, Tzankov, A, Dirnhofer, S, Fend, F, Greil, R, Siebert, R, ...

Background: The most frequent cytogenetic alteration in gastrointestinal (GI) B cell lymphoma (BCL) is t(11;18)(q21;q21). GI B cell non-Hodgkin lymphomas lacking this translocation vary in their...

Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.

Stauder, R, Greil, R, Schulz, T F, Thaler, J, Gattringer, C, Radaskiewicz, T, ...

In 160 non-Hodgkin lymphomas (NHL) of B and T cell origin the expression of leucocyte function-associated antigen-1 (LFA-1) and one of its counter-structures named 7F7-antigen was studied. Functional...

Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

Greil, R, Gattringer, C, Schulz, T, Knapp, W, Radaskiewicz, T, Dierich, M P, ...

In the majority of 188 non-Hodgkin lymphomas (NHL) investigated in this study, we found a simultaneous expression of the receptors for c3b and c3d (CR1 & CR2; cccorr = 0.69, P less than 0.0005). An...

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, ...

The purpose of this trial was to investigate the efficacy of adjuvant chemotherapy with 5-fluorouracil (5-FU) and leucovorin (LV) in stage II colon cancer. Patients with stage II colon cancer were...